Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · GHB

GHB in Trinidad and Tobago: not individually verified

Not individually verified

We have not confirmed that GHB specifically is scheduled in Trinidad and Tobago, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. No entry for GHB was found in the instruments read: the Dangerous Drugs Act, Chap. 11:25, as updated to 31 December 2016, and the Orders amending its First, Second and Fourth Schedules, Legal Notices No. 343, 345 and 346 of 2019, 166 of 2023, 131 of 2024 and 293 of 2026. Searches for «GHB», «hydroxybut», «oxybate», «GBL» and «butyrolactone» returned no line; the only lines containing «butyr» are the opioid entries «Dioxaphetyl butyrate» in the First Schedule and «Parafluoro butyrfentanyl» in Legal Notice No. 343 of 2019, both read and rejected. This cell asserts no placement. Whether gamma hydroxybutyrate is controlled by an instrument outside that set, including any other Regulations under section 57, was not read. The search is stated as the Schedules stand after Legal Notice No. 293 of 2026, read 3 October 2026.

Confirm directly with Trinidad and Tobago’s national drug authority or your own embassy before you rely on anything.

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.